Nuveen Asset Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7.72M | Sell |
409,637
-263,917
| -39% | -$4.97M | ﹤0.01% | 1741 |
|
|
2024
Q3 | $15.1M | Sell |
673,554
-307,613
| -31% | -$6.91M | ﹤0.01% | 1365 |
|
|
2024
Q2 | $20.5M | Buy |
981,167
+562,344
| +134% | +$11.7M | 0.01% | 1111 |
|
|
2024
Q1 | $6.16M | Sell |
418,823
-115,042
| -22% | -$1.69M | ﹤0.01% | 1867 |
|
|
2023
Q4 | $5.51M | Sell |
533,865
-129,395
| -20% | -$1.34M | ﹤0.01% | 1923 |
|
|
2023
Q3 | $5.21M | Sell |
663,260
-4,157
| -0.6% | -$32.7K | ﹤0.01% | 1847 |
|
|
2023
Q2 | $6.67M | Sell |
667,417
-2,556
| -0.4% | -$25.5K | ﹤0.01% | 1751 |
|
|
2023
Q1 | $5.95M | Sell |
669,973
-20,392
| -3% | -$181K | ﹤0.01% | 1791 |
|
|
2022
Q4 | $7.58M | Buy |
690,365
+137,709
| +25% | +$1.51M | ﹤0.01% | 1671 |
|
|
2022
Q3 | $7.2M | Buy |
552,656
+228,071
| +70% | +$2.97M | ﹤0.01% | 1683 |
|
|
2022
Q2 | $4.11M | Buy |
324,585
+219,194
| +208% | +$2.78M | ﹤0.01% | 2073 |
|
|
2022
Q1 | $1.44M | Buy |
105,391
+10,614
| +11% | +$145K | ﹤0.01% | 2664 |
|
|
2021
Q4 | $2.49M | Sell |
94,777
-7,082
| -7% | -$186K | ﹤0.01% | 2464 |
|
|
2021
Q3 | $3.67M | Sell |
101,859
-46,900
| -32% | -$1.69M | ﹤0.01% | 2374 |
|
|
2021
Q2 | $3.95M | Buy |
148,759
+8,702
| +6% | +$231K | ﹤0.01% | 2360 |
|
|
2021
Q1 | $4.35M | Buy |
140,057
+41,216
| +42% | +$1.28M | ﹤0.01% | 2229 |
|
|
2020
Q4 | $3.25M | Buy |
98,841
+31,991
| +48% | +$1.05M | ﹤0.01% | 2272 |
|
|
2020
Q3 | $2.33M | Buy |
+66,850
| New | +$2.33M | ﹤0.01% | 2301 |
|